Published ahead of print on March 16, 2006, doi:10.1164/rccm.200508-1218OC
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 1208-1215, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200508-1218OC
Regional Fibroblast Heterogeneity in the Lung
Implications for Remodeling
Chakradhar Kotaru,
Kathryn J. Schoonover,
John B. Trudeau,
Mai-Lan Huynh,
XiuXia Zhou,
Haizhen Hu and
Sally E. Wenzel
National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado
Correspondence and requests for reprints should be addressed to Chakradhar Kotaru, M.D., National Jewish Medical and Research Center, D203 1400 Jackson Street, Denver, CO 80206. E-mail: kotaruc{at}njc.org
Rationale: Excessive deposition of extracellular matrix occurs in proximal airways of individuals with asthma, but fibrosis in distal lung has not been observed. Whether differing fibrotic capacities of fibroblasts from these two regions contribute to this variability is unknown.
Objectives: We compared morphologic and functional characteristics of fibroblasts isolated from proximal airways and distal lung parenchyma to determine phenotypic differences.
Methods: Concurrent proximal airway and distal lung biopsies were obtained by bronchoscopy from subjects with asthma to isolate airway and distal lung fibroblasts, respectively. The following characteristics were compared: morphology, proliferation, -smooth muscle actin expression, and synthesis of procollagen type I and eotaxin-1.
Results: Airway fibroblasts (AFs) are morphologically distinct from distal lung fibroblasts (DLFs): they are larger (2.3-fold greater surface area vs. matched DLFs; p = 0.02), stellate in appearance, and with more cytoplasmic projections compared with the spindle-shaped DLFs. AFs synthesized more procollagen type I than did DLFs at baseline (twofold higher; p = 0.003) and after transforming growth factor- stimulation (1.4-fold higher; p = 0.02). Similarly, AFs produced more eotaxin-1 than did DLFs at baseline (2.5-fold higher; p = 0.004) and after interleukin-13 stimulation (13-fold higher; p = 0.0001). In contrast, DLFs proliferate more than AFs with serum stimulation (about sixfold greater; p = 0.03). Unstimulated DLFs also expressed more -smooth muscle actin than did corresponding AFs (p = 0.006).
Conclusions: These studies suggest that at least two phenotypes of fibroblast exist in the lung. These phenotypic differences may partially explain the variable responses to injury and repair between proximal airways and distal lung/parenchyma in asthma and other respiratory diseases.
Key Words: asthma fibroblast interleukin 13 remodeling transforming growth factor 
This article has been cited by other articles:

|
 |

|
 |
 
S. Togo, O. Holz, X. Liu, H. Sugiura, K. Kamio, X. Wang, S. Kawasaki, Y. Ahn, K. Fredriksson, C. M. Skold, et al.
Lung Fibroblast Repair Functions in Patients with Chronic Obstructive Pulmonary Disease Are Altered by Multiple Mechanisms
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
248 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Burstein, E. Libby, A. Calderone, and S. Nattel
Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences
Circulation,
April 1, 2008;
117(13):
1630 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sugiura, X. Liu, F. Duan, S. Kawasaki, S. Togo, K. Kamio, X. Q. Wang, L. Mao, Y. Ahn, R. F. Ertl, et al.
Cultured Lung Fibroblasts from Ovalbumin-Challenged "Asthmatic" Mice Differ Functionally from Normal
Am. J. Respir. Cell Mol. Biol.,
October 1, 2007;
37(4):
424 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Moore and S. P. Peters
Update in Asthma 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
649 - 654.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden
Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L405 - L413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wenzel and S. Balzar
Myofibroblast or smooth muscle: do in vitro systems adequately replicate tissue smooth muscle?
Am. J. Respir. Crit. Care Med.,
August 15, 2006;
174(4):
364 - 365.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|